Literature DB >> 30044914

Enhanced Opsonization-Independent Phagocytosis and High Response Ability to Opsonized Antigen-Antibody Complexes: A New Role of Kupffer Cells in the Accelerated Blood Clearance Phenomenon upon Repeated Injection of PEGylated Emulsions.

Xiaobo Cheng1, Chunling Wang1, Yuqing Su1, Xiang Luo1, Xinrong Liu1, Yanzhi Song1, Yihui Deng1.   

Abstract

The accelerated blood clearance (ABC) phenomenon is an immune response against the first injection of PEGylated colloidal drug delivery systems (CDDSs), which causes the accelerated clearance of the second dose. The enhanced complement-mediated phagocytic activity of Kupffer cells is responsible for accelerated second-dose clearance. Nevertheless, few studies have focused on the role of Kupffer cells in the induction phase of the ABC phenomenon. In this study, the intrinsic phagocytic activity of Kupffer cells was significantly enhanced at 6 days after the initial injected PEGylated emulsions (PEs) using the carbon clearance test and single-pass liver perfusion experiment. Furthermore, PE could stimulate Kupffer cells activation, leading to enhanced cell viability of Kupffer cells and opsonization-independent cellular uptake. It was also found that the response ability of Kupffer cells to the antigen-antibody complexes was augmented by the first injection of PE. Conclusively, we proposed that, besides anti-PEG IgM and complement activation-mediated hepatic uptake, enhanced opsonization-independent phagocytosis of Kupffer cells and the high response ability to opsonized antigen-antibody complexes contribute to the accelerated clearance of the second administration. The results indicated that Kupffer cells play an indispensable role in the ABC phenomenon and provided novel insights into the current view on the mechanism of the ABC effect.

Entities:  

Keywords:  Kupffer cells; PEGylated emulsions; accelerated blood clearance phenomenon; opsonization-independent phagocytosis; response ability

Mesh:

Substances:

Year:  2018        PMID: 30044914     DOI: 10.1021/acs.molpharmaceut.8b00019

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  2 in total

1.  A higher dose of PEGylated gold nanoparticles reduces the accelerated blood clearance phenomenon effect and induces spleen B lymphocytes in albino mice.

Authors:  Ahmed M Abu-Dief; Mosa Alsehli; Aziz Awaad
Journal:  Histochem Cell Biol       Date:  2022-02-14       Impact factor: 4.304

Review 2.  Toxicity and immunogenicity concerns related to PEGylated-micelle carrier systems: a review.

Authors:  Kouichi Shiraishi; Masayuki Yokoyama
Journal:  Sci Technol Adv Mater       Date:  2019-04-15       Impact factor: 8.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.